Published in Pharma Business Week, June 18th, 2012
In recent years, the role of Medical Science Liaisons (MSLs) has expanded across a diverse set of customers that now include regional thought leaders, important clinical investigators, local opinion leaders, payers and government thought leaders. In the face of these growing responsibilities, many biopharmaceutical and medical device companies are finding it increasingly challenging for their MSL groups to deliver exceptional services.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Business Week